Connect with us

Business

GITEX DIGI_HEALTH 5.0 Dubai showcases the future of Artificial Intelligence (AI)-driven innovations

Published

on

GITEX

The event aligns with the UAE government’s pioneering efforts to advance the digital health ecosystem, with the UAE’s digital health market projected to reach USD $487.30 million by the end of this year

DUBAI, United Arab Emirates, October 16, 2024/APO Group/ —

  • Innovators and leaders from the most influential medical labs, hospitals, healthcare institutions, research centres and academia gathered in Dubai to discuss AI opportunities
  • Neurology and remote patient monitoring were among the key topics on the agenda for discussion
  • Tech enterprises and providers showcased the most impactful digital solutions to accelerate connectivity and drive transformation

Transformative health tech solutions were at the heart of conversations at GITEX GLOBAL’s GITEX DIGI_HEALTH 5.0 Dubai (www.GITEX.com), where thousands of tech enthusiasts and healthcare pioneers converged at Dubai World Trade Centre (DWTC) for a day of future health discussions.

The world’s largest tech event provided a platform to showcase the latest AI-driven digital health and health tech solutions, spotlighting innovations that are reshaping patient care on a global scale.

The event aligns with the UAE government’s pioneering efforts to advance the digital health ecosystem, with the UAE’s digital health market projected to reach USD $487.30 million by the end of this year. The show also supports Dubai’s commitment to adopting digital practices that benefit medical professionals and patients alike.

With AI-powered healthcare investments projected to make up 20% of global healthcare spending by year’s end, GITEX GLOBAL set the stage for industry leaders to explore how AI is revolutionising delivery and enhancing outcomes for millions of patients.

GITEX DIGI_HEALTH 5.0 Dubai brought together global professionals and leaders to build on that figure and discuss the impact the innovative tool is having on the day-to-day operations while also providing an outlook of what the future would hold. It attracted some of the biggest names in the global landscape including labs such as Biogen, Roche and Sanofi as well as tech giants Microsoft, M42, Lenovo. Also present were established medical institutions including Samsung Medical Centre, Harvard Medical School, Roche and many more.

Pioneering Robotic and AI in Digital Health

The evolving role of robotics in health tech was a major focus of the showcase and conference programme. Denis Ledenkof, Founder of Robosculptor, showcased how AI-powered robotics is transforming patient care via an autonomous platform for body treatments developed by health industry experts, emphasising robotic technology is providing plenty of benefits.

When it comes to robotic treatments, they help improve the experience of patients by just giving them access to a wider range of therapies as well as enhancing accessibility

He said: “AI is a powerful tool and is leading to better patient preferences. When it comes to robotic treatments, they help improve the experience of patients by just giving them access to a wider range of therapies as well as enhancing accessibility.

One example that we’re using is an application that functions similarly to a taxi or delivery app where people can scan for treatments and displays the information that users would be looking for.”

Alex Aliper, Co-Founder and President of Insilico Medicine, a Hong Kong digital health unicorn – was part of another panel that delved into genomics. He discussed how precision medicine, powered by AI, is revolutionising genetic profiles – an approach set to transform treatments for diseases previously deemed incurable.

The future of AI in neurology

Meanwhile, following a study which showed that AI can reduce the risk of new vascular events by 25.6% in stroke patients, Aneesh Singhal, M.D, Director, Comprehensive Stroke Center & Vice-Chair of Neurology at Massachusetts General Hospital, gave an overview of what to expect in the field of neurology.

In his presentation, he discussed the Golden Bridge II trial, which showed that the use of an AI-based clinical decision support system had a significantly greater impact on the number of vascular events and stroke care quality than standard care in patients with acute ischemic stroke (AIS).

Elsewhere, Jong-Soo Choi, Chief Technology Officer at Samsung Medical Centre, one of Korea’s most renowned hospitals, shared insights into cutting-edge technologies such as Remote Patient Monitoring (RPM) and gene therapy and how they are setting the stage for the next wave of change.

Smart lens among innovations unveiled

Dubai’s own deep tech company Xpanceo made waves with the unveiling of smart contact lens for 3D imaging, and another for data reading, demonstrating wireless data transmission capabilities integrated directly into the lens. These innovations are set to redefine the boundaries of how data in real time is perceived, pushing the digital health landscape into a new era of smart diagnostics.

Oracle Health also displayed its innovative Clinical Digital Assistant. Leveraging AI-powered driven voice recognition, the assistant autonomously documents physician-patient encounters, interprets the information, and accurately inputs a draft note into the Oracle Health EHR, allowing the physician to quickly review and approve the clinical documentation.

GITEX GLOBAL is seamlessly connecting the world’s largest network of tech events with GITEX EUROPE Berlin, GITEX ASIA Singapore, GITEX AFRICA Morocco, and GITEX NIGERIA all part of its portfolio. These events are fostering collaboration and driving innovation to shape the tech landscape of tomorrow.

GITEX GLOBAL this year announced the launch of GITEX DIGI_HEALTH 5.0 Expo-Summit in Thailand, from 10-12 September 2025, in a destination touted with one of the highest potentials to leapfrog the digital health industry, putting the spotlight on digital solutions to address the rising demands across Asia.

More information on GITEX GLOBAL and to purchase passes, please visit www.GITEX.com

Distributed by APO Group on behalf of GITEX Global.

Business

Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt

Published

on

EVA Pharma

This milestone stems from the companies’ collaboration to expand access to affordable insulin to one million people living with diabetes in low-to middle-income countries annually by 2030

CAIRO, Egypt, December 17, 2024/APO Group/ — 

The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma (www.EVAPharma.com) through a collaboration with Eli Lilly and Company (NYSE: LLY). Launched in 2022, the collaboration aims to deliver a sustainable supply of high-quality, affordable human and analog insulin to at least one million people annually living with type 1 and type 2 diabetes in low- to middle-income countries (LMICs), most of which are in Africa. 

This marks the first regulatory approval of EVA Pharma’s insulin drug products, following Lilly and EVA Pharma’s collaboration (https://apo-opa.co/41xlg6K) announcement in December 2022. Under this agreement, Lilly has been supplying its active pharmaceutical ingredient (API) for insulin to EVA Pharma at a significantly reduced price and providing pro-bono technology transfer to enable EVA Pharma to formulate, fill and finish insulin vials and cartridges.

Less than two years after the initial announcement, EVA Pharma has completed a new biologics manufacturing facility, finalized insulin formulations and stability testing processes, engaged with the local regulatory authorities to obtain approval of the insulin glargine injection, and released the first batch of the locally manufactured insulin drug product.

We will continue to work with global health systems and industry stakeholders to address systemic barriers to healthcare and expand equitable, affordable access to our medicines

Additionally, EVA Pharma’s human insulin injection was also submitted for local regulatory approval. Lilly and EVA Pharma continue working with the World Health Organization (WHO) to secure WHO pre-qualification for the locally manufactured human insulin injection. The WHO pre-qualification will further ensure that medicines manufactured by EVA Pharma meet the high-quality standards set by WHO.

“For more than a century, Lilly has been at the forefront of diabetes care, offering innovative solutions that make life better for people around the world,” said Ilya Yuffa, executive vice president and president of Lilly International. “Our collaboration with EVA Pharma furthers our commitment to providing sustainable and accessible medicines worldwide. We will continue to work with global health systems and industry stakeholders to address systemic barriers to healthcare and expand equitable, affordable access to our medicines to transform more people’s lives.”

“Localizing essential medicines is the key to driving equitable access to healthcare,” said Riad Armanious, CEO of EVA Pharma. “It takes bold collaboration, cutting-edge innovation, and tech-driven manufacturing to turn this vision into reality. Our collaboration with Lilly shows what’s possible when we push boundaries together. This is just the beginning—we’re on track to impact over a million lives annually across 56 countries, making a real difference for people living with diabetes.”

This collaboration is part of the Lilly 30×30 initiative, which aims to improve access to quality health care for 30 million people living in resource-limited settings annually by 2030.

Most recently, Lilly and EVA Pharma expanded their collaboration, announcing (https://apo-opa.co/3ZCUhUJ) that Lilly will license certain baricitinib manufacturing know-how to enable EVA Pharma to manufacture and supply treatment for various immunological diseases across 56 low- to middle-income countries in Africa.

Distributed by APO Group on behalf of EVA Pharma.

Continue Reading

Business

Cassava Technologies Secures USD 310 Million in Funding and Completes Business Reorganization

Published

on

Cassava Technologies

This funding is a key part of Cassava’s plan to strengthen its balance sheet, drive sustainable profitable growth, and cement its position as a global technology company of African heritage

LONDON, United Kingdom, December 17, 2024/APO Group/ — 

Cassava Technologies (Cassava) (www.CassavaTechnologies.com), a global technology leader of African heritage, proudly announces three significant milestones: a substantial equity injection, the successful completion of its South African Rand (ZAR) debt refinancing, and the finalization of its legal reorganization. These strategic initiatives position Cassava for robust growth underpinned by a strong balance sheet.

Cassava has closed an equity investment round of $90 million with participation from U.S. International Development Finance Corporation (DFC), Finnish Fund for Industrial Cooperation (Finnfund), and Google LLC. This funding is a key part of Cassava’s plan to strengthen its balance sheet, drive sustainable profitable growth, and cement its position as a global technology company of African heritage.

The conclusion of this equity round coincides with the successful reorganization of Cassava’s business to create an integrated digital solutions platform. This platform provides Broadband Connectivity, Co-location (data centres), Cloud, Cybersecurity, Compute (AI), and Payment services across more than 30 markets in Africa, the Middle East, India, and Latin America.

We are excited to announce these significant achievements, which collectively strengthen our financial position

Additionally, Liquid Intelligent Technologies, a business of Cassava Technologies, has successfully signed new facilities to refinance its South African Rand term loan on a multi-tenor basis. The new facilities, equivalent to USD 220 million in South African Rands, are being provided by Standard Bank of South Africa, Rand Merchant Bank, Nedbank of South Africa, and International Finance Corporation (IFC).

“We are excited to announce these significant achievements, which collectively strengthen our financial position and are a powerful testament to the vision of our founder and Group Chairman, Strive Masiyiwa, and the dedication and commitment of our teams across the Group,” said Hardy Pemhiwa, President and Group CEO of Cassava. “The closing of this equity round, completion of our ZAR debt refinancing, and reorganization represent more than just capital – it’s a pivotal milestone that we expect to unlock immense value and catalyze the further expansion of our digital infrastructure and services to bridge the digital divide on the continent”.

With the addition of DFC, Google LLC, and Finnfund, Cassava’s impressive roster of shareholders includes Econet Group, British International Investment (BII), Public Investment Corporation (PIC), Royal Bafokeng Holdings (RBH), Africa-Export Import Bank (Afreximbank/FEDA), and Gateway Capital.

Cassava Technologies has built a strong portfolio of business units comprising Liquid Intelligent Technologies, Africa Data Centres, Liquid C2, Cassava.ai, and Sasai Fintech, all of which are leaders in their respective sectors. This integrated platform of business units enables the Group to fulfill its vision of a digitally connected future that leaves no African behind.

Distributed by APO Group on behalf of Cassava Technologies.

Continue Reading

Business

How global payroll can boost global business

Published

on

payroll

Modern payroll platforms are cutting through cross-border payroll issues that erode business performance

JOHANNESBURG, South Africa, December 17, 2024/APO Group/ — 

Can global payroll truly exist in an era where business is increasingly international, and employees work from more places and locations than the office? More specifically, organisations need a single, global payroll platform with configuration, scalability, and compliance across all sizes and locations to achieve flexible global payroll management. Is that achievable?

Business might go global, but payroll often remains very local. No matter which country one operates in, local regulations and requirements dictate payroll in that area. According to the 2021 “Getting the World Paid” survey (https://apo-opa.co/4ixXH3T), compliance is the biggest global payroll challenge.

“The enormous amount of variable administration can make it very difficult to manage payrolls in different regions under one umbrella,” says Heinrich Swanepoel, Head of Growth at PaySpace by Deel. “Every territory has different requirements. Navigating those local requirements is tricky and creates layers of bureaucracy. It becomes very expensive once you operate in a few territories.”

Payroll dampens global business

According to Forrester (https://apo-opa.co/3DgZY2Z), almost half of payroll administrators encountered substantial hidden costs when managing global payrolls. Compliance, language barriers, tax calculations, labour relations, and fluctuating exchange rates are among the culprits. But, the underlying issue is that different payroll administration is often fractured by necessity, relying on local representatives to manage that territory’s payroll on behalf of a company.

While that solves some of the problems, it’s impossible with traditional payroll systems to consolidate and centralise management on a global scale. Companies that achieve this do so with very fractured systems, incurring substantial costs and other risks.

“I’ve met many companies that want to expand into new regions but then reduce their plans or abandon them due to payroll management, transparency, or cost issues. That is a pity because they won’t have to have these problems if they used integrated payroll platforms,” says Swanepoel.

Global expansions are risky, and most companies don’t profit from their cross-border expansions (https://apo-opa.co/3VK4GN7). Any edge will help, and integrated global payroll management can turn overseas folly into victory. But what does integrated global payroll look like?

Winning with integrated payroll platforms

Companies reduce risks by centralising their payroll systems, including data breaches, fraud, and fines

An integrated payroll system has several attributes, some laying the foundation for more advanced features. Centralisation helps companies reduce risks by consolidating their payroll data and processes. Using integration, companies can connect payroll with finance and human resource systems, further reducing administrative overhead—especially when they start to automate processes, says Swanepoel:

“Automation removes many manual checks that take time and create opportunities for payroll fraud. An integrated centralised payroll system exchanges information with other business systems. When you start automating processes based on those exchanges, you can run continuous payroll that operates efficiently throughout the month, not just at the end.”

Centralisation through integration and automation also delivers other benefits, such as standard data sets, centralised management and reporting, streamlined enrolment, and adding advanced features such as self-service portals for employees. Every business should aspire for an integrated payroll environment, not only those looking to go global.

Fixing global payroll

However, a centralised and integrated payroll system can sound much like regional payroll systems. These are not capable of handling global payroll needs. But there is a new breed of payroll system that can handle global requirements while supporting centralisation, integration, and automation, and it remains flexible and affordable—global payroll platforms.

“The best global payroll platforms have ways to overcome typical issues that in-house and traditional software cannot. For example, they monitor different regions for legislative changes and apply them to their platform, which reflects immediately for all their customers. You can only do this with a cloud-native multi-tenant platform. The payroll service provider runs the platform, and each customer company accesses a secure instance meant specifically for them. That way, every customer gets updates without needing to do anything.”

These platforms naturally incorporate features such as automation, single data standards, and controlled access so that different departments can access payroll information and reports. They effortlessly cross borders, accommodating different cultures, languages, and sovereign laws.

Deel is the very first payroll platform to have been able to achieve these goals and allocate the resources to create global payroll coverage. But there are exceptions. For example, Deel recently acquired payroll platform PaySpace to offer global payroll and employee-of-record services on one software-as-a-service platform that serves multiple regions. This revolutionary bundling and delivery are poised to change how organisations manage local and global payrolls.

“A cloud-native payroll platform radically reduces the costs and risks associated with managing global payroll,” says Swanepoel. “You get payroll systems tailored to each territory you operate in. But there is no fracturing because they all interconnect on the same platform, and costs are lower because you save by automating processes, reducing administration, and don’t have to chase legislative changes. If you pay people in different jurisdictions, you should use a cloud-native integrated payroll platform. There really is no better choice.”

Distributed by APO Group on behalf of PaySpace.

Continue Reading

Trending